Inhibrx, Inc. announced the formation of a Scientific Advisory Board for its INBRX-101 program for the treatment of alpha-1 antitrypsin deficiency ("AATD"). The SAB is comprised of the top global experts in AATD and will work closely with Inhibrx management to help guide the development of INBRX-101 to registration and beyond. The founding members of the Inhibrx INBRX-101 SAB are: Igor Barjaktarevic, M.D., Ph.D., is an Associate Professor at the David Geffen School of Medicine at UCLA and works at Ronald Reagan Medical Center, both in Los Angeles, California.

Mark Brantly, M.D., is a Professor of Medicine and the Vice Chair of Research in the Department of Medicine at the University of Florida. He graduated from the University of Florida College of Medicine in Gainesville, Florida. Kenneth R. Chapman, M.D., MSc, FRCPC, FACP, FERS, is a Professor of Medicine at the University of Toronto in Ontario, Canada and the founder and current president of Inspiration Research Limited.

He serves as the Director of the Asthma and Airway Centre of the University Health Network, President of the Canadian Network for Respiratory Care, and Director of the Canadian Registry for AATD. Noel Gerry McElvaney, M.D., BCh, BAO, FRCPI, FRCPC is a Professor of Medicine and the Chairman of the Department of Medicine at the Royal College of Surgeons in Dublin, Ireland. He graduated from the School of Medicine at the University College in Dublin, Ireland and completed his fellowship in respiratory medicine at the University of British Columbia, Vancouver, Canada.

His expertise is in the areas of cystic fibrosis, AATD, infection, immunity, and lung inflammation. Dr. McElvaney founded the Alpha-1 Foundation of Ireland in 2001 to provide a patient forum and to promote awareness of AATD. Robert A. Sandhaus, M.D., Ph.D., FCCP, is a Professor of Medicine at the National Jewish Health in Denver, Colorado.

He is also the Executive Vice President and Senior Medical Director of AlphaNet and the Clinical Director of the Alpha-1 Foundation, two not-for-profit organizations serving the Alpha-1 community. Dr. Sandhaus received both his medical degree and his Ph.D. from Stony Brook University School of Medicine in Stony Brook, New York. James Stoller, M.D., M.S., is the Chair of the Education Institute at the Cleveland Clinic Lerner College of Medicine and is an Adjunct Professor of Organizational Behavior at the Weatherhead School of Management at Case Western Reserve University, both in Cleveland, Ohio.

He earned his medical degree from Yale University School of Medicine and completed his residency at Peter Bent Brigham Hospital in Boston, Massachusetts. He completed fellowships in pulmonary disease and critical care medicine at both Brigham and Women's Hospital in Boston, Massachusetts and Yale University School of Medicine in New Haven, Connecticut, as well as a fellowship in critical care medicine and anesthesia at Massachusetts General Hospital in Boston, Massachusetts.